Delivery Order SPE2DB22D3501-SPE2DB25FXM05
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $2,387.01 to AmerisourceBergen Drug Corp for Annovera vaginal rings. This is a firm fixed-price, competitively awarded contract with a completion date of September 23, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,295.78 to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA and is being performed at the contractor's Conshohocken, Pennsylvania location. The award carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $2,954.22 to AmerisourceBergen Drug Corp for Annovera vaginal rings on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price, non-set-aside delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order totaling $1,377.53 to AmerisourceBergen Drug Corp for Annovera vaginal rings on June 2, 2025, with completion expected by June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,506.26 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This competitive award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,373.73 to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania. Annovera is a long-acting contraceptive...
- The Defense Logistics Agency awarded a delivery order valued at $3,470.72 to AmerisourceBergen Drug Corp for Annovera vaginal rings on July 16, 2025, with an ultimate completion date of July 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,375.23 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. The contract, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,620.00 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings, with an ultimate completion date of July 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $5,012.52 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This competitively awarded contract, with no set-aside designation, was executed on June 25, 2025, with an ultimate completion date of June 26, 2025, and reflects a firm fixed price arrangement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXM05Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,029.04 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This competitive award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed-price delivery order under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government medical supply programs. This delivery order is issued as a child contract under AmerisourceBergen's existing SPE2DX indefinite delivery contract with DLA valued at $999.999 billion through December 2026. The SPE2DX vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Annovera vaginal rings represent a specialized medical commodity within the company's extensive portfolio of brand-name and generic medications, vaccines, and medical devices delivered through competitively awarded contracts with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/22/25 |